查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433641

獸醫原料藥製造市場規模、佔有率、趨勢分析報告：按動物類型、按服務類型、按合成類型、按治療產品類別、按細分市場預測，2024-2030年

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, Share & Trends Analysis Report By Animal Type (Production, Companion), By Service Type, By Synthesis Type, By Therapeutic Category, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

獸藥原料藥製造市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球獸用原料藥製造市場規模預計將達到134.7億美元，2024年至2030年複合年成長率為6.8%。

推動市場成長的主要因素包括動物數量的增加和寵物的人性化、寵物的高支出、主要市場參與者的舉措、將製造功能外包給第三方、動物疾病的高流行等。例如，軒藥業從事獸藥生產，生產各種原料藥，涵蓋治療類別、目標物種和合成類型。該公司生產兩種專有 API：泰妙菌素和鹽酸四環素。

將製造功能外包給第三方是市場成長的主要動力。這使得製藥公司能夠專注於研發、監管事務和行銷等核心競爭力。對核心能力的策略關注提高了整體業務效率，並加速了新型獸用原料藥的開發和商業化。透過外包給精通獸藥的 CMO，製藥公司可以利用經驗豐富的專業人員的專業技能。擁有高效製造流程的 CMO 可以加快製造進度，使公司能夠更快地將產品推向市場並快速回應新的市場需求。

監管機構和動物健康組織的舉措預計也將推動市場成長。例如，2023 年 9 月，美國FDA 宣布了一項促進動物生物技術和獸醫創新的議程，作為動物和獸醫創新議程的一部分。該議程旨在使 FDA 評估和支持創新獸藥開發的方法現代化，並提高監管效率、彈性和可預測性。政府增加有助於改善動物健康的措施預計也將推動整體市場的成長。旨在加強動物保健標準的「同一個健康計畫」的推出改善了該行業的成長前景。該合作計劃將整合臨床護理、疾病監測、教育和研究，以更好地控制該疾病。

獸藥原料藥製造市場報告亮點

  • 到 2023 年，化學原料藥細分市場將以 71.3% 的佔有率佔據市場主導地位。預計 2024 年至 2030 年，生物 API 領域將以 8.3% 的複合年成長率成長最快。
  • 2023 年，生產性動物部門佔收益佔有率最大。預計 2024 年至 2030 年，伴同性動物細分市場將以最快的速度成長。
  • 2023 年，內部部門的收益佔有率最高。預計委託領域在預測期內將以最快的複合年成長率成長。
  • 2023年感染疾病品領域佔比最高。其他治療領域包括腫瘤學、糖尿病和其他藥物。
  • 2023 年，北美地區市場領先，同年收益佔有率最大，達 37.8%。同時，預計 2024 年至 2030 年亞太地區的複合年成長率將達到 7.9%，是最快的。
  • 由於動物疾病的高發生率以及人們對寵物保健的興趣日益濃厚，對獸藥的需求不斷成長，這推動了對獸用原料藥的需求。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章獸用 AP 製造市場：變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
  • 獸藥原料藥製造市場分析工具
  • 2023 年以主要物種和主要國家估計的動物數量
  • COVID-19 影響分析

第 4 章 獸用 AP 製造市場：服務類型估計與趨勢分析

  • 細分儀表板
  • 獸醫 API 製造市場：2023 年和 2030 年服務類型變化分析
  • 在內部
  • 委託

第5章 獸用 AP 製造市場：合成類型的估算與估算/趨勢分析

  • 細分儀表板
  • 獸用 AP 製造市場：2023 年和 2030 年合成類型變化分析
  • 基於化學的API
  • 生物原料藥
  • HP API

第6章獸用 AP 製造市場：動物類型估計和趨勢分析

  • 細分儀表板
  • 獸藥 API 製造市場：動物類型變化分析，2023 年和 2030 年
  • 生產動物
  • 伴同性動物

第7章獸藥原料藥製造市場：治療藥物類別估算及趨勢分析

  • 細分儀表板
  • 獸藥原料藥製造市場：2023年及2030年治療藥物類別波動分析
  • 驅蟲藥
  • 感染疾病
  • NSAID
  • 其他

第8章獸用原料藥製造市場：區域估計與趨勢分析

  • 2023 年和 2030 年按地區分類的獸用 AP 製造市場佔有率
  • 區域展望
  • 北美洲
    • 2018 年至 2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018 年至 2030 年市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 2018-2030 年市場估計與預測
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018 年至 2030 年市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 2018 年至 2030 年市場估計與預測
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第9章 競爭形勢

  • 市場參與企業分類
  • 企業市場分析/堆圖分析
  • 公司簡介
    • Zoetis
    • Alivira Animal Health Limited
    • Ofichem Group
    • Chempro Pharma Private Limited
    • Siflon Drugs
    • Qilu Animal Health Products Co., Ltd.
    • Vetpharma
    • SUANFARMA
    • MENADIONA
    • Excel Industries Ltd.
  • 策略規劃
    • 併購
    • 夥伴關係與協作
    • 其他
  • 其他主要市場參與者名單
Product Code: GVR-4-68039-328-0

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth & Trends:

The global veterinary active pharmaceutical ingredients manufacturing market size is expected to reach USD 13.47 billion by 2030, registering a CAGR of 6.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The key factors driving market growth include rising animal population & pet humanization, high pet expenditure, initiatives by key market players, outsourcing of manufacturing functions to third parties, and a high prevalence of diseases in animals. Suanfarma, for instance, is involved in the veterinary manufacturing of a wide range of APIs across therapeutic categories, target species, and synthesis types. The company manufactures two proprietary APIs, namely, Tiamulin and Tetracycline HCl.

Outsourcing the manufacturing function to third parties is a significant driver of the market growth. This enables pharmaceutical companies to concentrate on their core competencies, such as R&D, regulatory affairs, and marketing. This strategic focus on core functions enhances overall operational efficiency and accelerates the development and commercialization of new veterinary APIs.Outsourcing to CMOs with expertise in animal health allows pharmaceutical companies to tap into the specialized skills of experienced professionals. This can improve product quality, compliance with regulatory standards, and enhanced manufacturing processes.Contract manufacturers with efficient processes can expedite the production timeline, allowing companies to launch their products more quickly and respond promptly to emerging market needs.

Initiatives by regulatory agencies and animal health organizations are also expected to drive market growth. For instance, in September 2023, the U.S. FDA released an agenda to promote innovation in animal biotech and veterinary products as part of the Animal and Veterinary Innovation Agenda. Thesesteps are intended to modernize the agency's approach to evaluating and supporting the development of innovative veterinary products thereby increasing regulatory efficiency, flexibility, and predictability. An increase in the number of government initiatives, that help promote animal health, is also expected to fuel the overall market growth. The launch of One Health Initiative for enhancing animal healthcare standards has improved growth prospects for the industry. This joint project unified clinical care, disease surveillance, and education & research areas for better control of diseases.

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Highlights:

  • The chemical-based API segment dominated the market with a share of 71.3% in 2023. The biological API segment is anticipated to grow at the fastest CAGR of 8.3% from 2024 to 2030
  • The production animals segment held the largest revenue share in 2023. The companion animals segment is projected to grow at the fastest growth rate from 2024 to 2030
  • The in-house service type segment accounted for the highest revenue share in 2023. The contract outsourcing segment is projected to grow the fastest CAGR over the forecast years
  • The anti-infectives segment held the highest share in 2023. The other therapeutic category segment includes oncology, diabetes, and other drugs
  • North America was the leading regional market in 2023 and held the largest revenue share of 37.8% in the same year. Asia Pacific, on the other hand, is anticipated to register the fastest CAGR of 7.9% from 2024 to 2030
  • The growing need for veterinary drugs & pharmaceuticals due to the high prevalence of animal diseases and an increasing focus on pet healthcare drive the demand for veterinary APIs

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Increasing uptake of CDMO services
      • 3.2.1.2. Increasing advancements in veterinary medicine
      • 3.2.1.3. Increasing prevalence of diseases in animals
      • 3.2.1.4. Increasing animal health expenditure
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Complex regulations
      • 3.2.2.2. Limited Awareness and Education
  • 3.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape
  • 3.4. Estimated Animal Population, by Key Species & Key Countries, 2023
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Service Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary active pharmaceutical ingredients manufacturing market: service type movement analysis, 2023 & 2030 (USD Million)
  • 4.3. In House
    • 4.3.1. In house market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4. Contract Outsourcing
    • 4.4.1. Contract outsourcing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Contract Development
      • 4.4.2.1. Contract development market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.2. Preclinical Development
      • 4.4.2.2.1. Preclinical development market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.3. Clinical Development
      • 4.4.2.3.1. Clinical development market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Contract Manufacturing
      • 4.4.3.1. Contract manufacturing market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Synthesis Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary active pharmaceutical ingredients manufacturing market: synthesis type movement analysis, 2023 & 2030 (USD Million)
  • 5.3. Chemical-based API
    • 5.3.1. Chemical-based API market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4. Biological API
    • 5.4.1. Biological API market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. HPAPI
    • 5.5.1. HPAPI market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Animal Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary active pharmaceutical ingredients manufacturing market: animal type movement analysis, 2023 & 2030 (USD Million)
  • 6.3. Production Animals
    • 6.3.1. Production animals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4. Companion Animals
    • 6.4.1. Companion animals market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Therapeutic Category Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary active pharmaceutical ingredients manufacturing market: therapeutic category movement analysis, 2023 & 2030 (USD Million)
  • 7.3. Antiparasitics
    • 7.3.1. Antiparasitics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4. Anti-infectives
    • 7.4.1. Anti-infectives market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. NSAIDs
    • 7.5.1. NSAIDs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Regional Estimates & Trend Analysis

  • 8.1. Veterinary active pharmaceutical ingredients manufacturing market share, by region, 2023 & 2030, (USD Million)
  • 8.2. Regional Outlook
  • 8.3. North America
    • 8.3.1. North America veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. U.S. veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Canada veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. UK veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Germany veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. France veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Italy veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Spain veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Sweden veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Denmark veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Norway veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. China veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Japan
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Japan veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. India veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. South Korea veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Australia veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Thailand veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Brazil veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Mexico
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Mexico veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. Argentina
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Argentina veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7. Middle East and Africa
    • 8.7.1. Middle East and Africa veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. UAE veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. South Africa
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. South Africa veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Kuwait veterinary active pharmaceutical ingredients manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Position Analysis/ Heap Map Analysis
  • 9.3. Company Profiles
    • 9.3.1. Zoetis
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Alivira Animal Health Limited
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Ofichem Group
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Chempro Pharma Private Limited
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Siflon Drugs
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Qilu Animal Health Products Co., Ltd.
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Vetpharma
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. SUANFARMA
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. MENADIONA
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Excel Industries Ltd.
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives
  • 9.4. Strategy Mapping
    • 9.4.1. Mergers & Acquisitions
    • 9.4.2. Partnerships & Collaborations
    • 9.4.3. Others
  • 9.5. List of Other Key Market Players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Global veterinary active pharmaceutical ingredients manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 4 Global veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 -2030 (USD Million)
  • Table 5 Global veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 6 Global veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 7 Global veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 8 Global veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 9 North America veterinary active pharmaceutical ingredients manufacturing market, by country, (USD Million) 2018 - 2030 (USD Million)
  • Table 10 North America veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 11 North America veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 12 North America veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 13 North America veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 14 North America veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 15 North America veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 16 U.S. veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 17 U.S. veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 18 U.S. veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 19 U.S. veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 20 U.S. veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 21 U.S. veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 22 Canada veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 23 Canada veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, (USD Million) 2018 - 2030 (USD Million)
  • Table 24 Canada veterinary active pharmaceutical ingredients manufacturing market, by service type, (USD Million) 2018 - 2030 (USD Million)
  • Table 25 Canada veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, (USD Million) 2018 - 2030 (USD Million)
  • Table 26 Canada veterinary active pharmaceutical ingredients manufacturing market, by contract development, (USD Million) 2018 - 2030 (USD Million)
  • Table 27 Canada veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, (USD Million) 2018-2030 (USD Million)
  • Table 28 Europe veterinary active pharmaceutical ingredients manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 29 Europe veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 30 Europe veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 31 Europe veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 32 Europe veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 33 Europe veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 34 Europe veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 35 Germany veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 36 Germany veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 37 Germany veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 38 Germany veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 39 Germany veterinary active pharmaceutical ingredients manufacturing , by contract development, 2018 - 2030 (USD Million)
  • Table 40 Germany veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 41 UK veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 42 UK veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, (USD Million) 2018- 2030 (USD Million)
  • Table 43 UK veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018-2030 (USD Million)
  • Table 44 UK veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018-2030 (USD Million)
  • Table 45 UK veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018-2030 (USD Million)
  • Table 46 UK veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 47 France veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 48 France veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 49 France veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 50 France veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 51 France veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 52 France veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 53 Italy veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 54 Italy veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 55 Italy veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 56 Italy veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 57 Italy veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 58 Italy veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 59 Spain veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 60 Spain veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 61 Spain veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 62 Spain veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 63 Spain veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 64 Spain veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 65 Denmark veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 66 Denmark veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 67 Denmark veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 68 Denmark veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 69 Denmark veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 70 Denmark veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 71 Sweden veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 72 Sweden veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 73 Sweden veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 74 Sweden veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 75 Sweden veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 76 Sweden veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 77 Norway veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 78 Norway veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 79 Norway veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 80 Norway veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 81 Norway veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 82 Norway veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 83 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 84 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 85 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 86 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 87 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 88 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 89 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 90 China veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 91 China veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 92 China veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 93 China veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 94 China veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 95 China veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 96 Japan veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 97 Japan veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 98 Japan veterinary active pharmaceutical ingredients manufacturing market, by service type, (USD Million) 2018-2030 (USD Million)
  • Table 99 Japan veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 100 Japan veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 101 Japan veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 102 India veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 103 India veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 104 India veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 105 India veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 106 India veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 107 India veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 108 South Korea veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 109 South Korea veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 110 South Korea veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 111 South Korea veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 112 South Korea veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 113 South Korea veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 114 Australia veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 115 Australia veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 116 Australia veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 117 Australia veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 118 Australia veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 119 Australia veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 120 Thailand veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 121 Thailand veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 122 Thailand veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 123 Thailand veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 124 Thailand veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 125 Thailand veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 126 Latin America veterinary active pharmaceutical ingredients manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 127 Latin America veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 128 Latin America veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 129 Latin America veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 130 Latin America veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 131 Latin America veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 132 Latin America veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 133 Brazil veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 134 Brazil veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 135 Brazil veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 136 Brazil veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 137 Brazil veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 138 Brazil veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 139 Mexico veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 140 Mexico veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 141 Mexico veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 142 Mexico veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 143 Mexico veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 144 Mexico veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 145 Argentina veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 146 Argentina veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 147 Argentina veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 148 Argentina veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 149 Argentina veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 150 Argentina veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 151 MEA veterinary active pharmaceutical ingredients manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 152 MEA veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 153 MEA veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 154 MEA veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 155 MEA veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 156 MEA veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 157 MEA veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 158 South Africa veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 159 South Africa Veterinary Active Pharmaceutical Ingredients Manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 160 South Africa veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 161 South Africa veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 162 South Africa veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 163 South Africa veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 164 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 165 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 166 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 167 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 168 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 169 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, (USD Million) 2018 - 2030 (USD Million)
  • Table 170 UAE veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 171 UAE veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 172 UAE veterinary active pharmaceutical ingredients manufacturing market, by service type, (USD Million) 2018-2030 (USD Million)
  • Table 173 UAE veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 174 UAE veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 175 UAE veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 176 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by animal type, 2018 - 2030 (USD Million)
  • Table 177 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by synthesis type, 2018 - 2030 (USD Million)
  • Table 178 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by service type, 2018 - 2030 (USD Million)
  • Table 179 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by contract outsourcing, 2018 - 2030 (USD Million)
  • Table 180 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by contract development, 2018 - 2030 (USD Million)
  • Table 181 Kuwait veterinary active pharmaceutical ingredients manufacturing market, by therapeutic category, 2018 - 2030 (USD Million)
  • Table 182 Company Overview
  • Table 183 Product Benchmarking
  • Table 184 Financial Performance
  • Table 185 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Veterinary active pharmaceutical ingredients manufacturing market outlook
  • Fig. 10 Veterinary active pharmaceutical ingredients manufacturing market snapshot
  • Fig. 11 Veterinary active pharmaceutical Ingredients Manufacturing market driver impact
  • Fig. 12 Veterinary active pharmaceutical ingredients manufacturing market restraint impact
  • Fig. 13 Porter's 5 Forces Analysis
  • Fig. 14 PESTEL Analysis
  • Fig. 15 Veterinary active pharmaceutical ingredients manufacturing market animal type key takeaways (USD Million)
  • Fig. 16 Veterinary active pharmaceutical ingredients manufacturing market: animal type movement & market share analysis, 2023 & 2030
  • Fig. 17 Global production animals market, 2018 - 2030 (USD Million)
  • Fig. 18 Global companion animals market, 2018 - 2030 (USD Million)
  • Fig. 19 Veterinary active pharmaceutical ingredients manufacturing market: Synthesis Type and key takeaways (USD Million)
  • Fig. 20 Veterinary active pharmaceutical ingredients manufacturing market: synthesis type movement & market share analysis, 2023 & 2030
  • Fig. 21 Global chemical based API market, 2018 - 2030 (USD Million)
  • Fig. 22 Global biological API market, 2018 - 2030 (USD Million)
  • Fig. 23 Global HPAPI market, 2018 - 2030 (USD Million)
  • Fig. 24 Veterinary active pharmaceutical ingredients manufacturing market: Service type & key takeaways (USD Million)
  • Fig. 25 Veterinary active pharmaceutical ingredients manufacturing market: Service type movement & market share analysis, 2023 & 2030
  • Fig. 26 Global in house market, 2018 - 2030 (USD Million)
  • Fig. 27 Global contract outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 28 Global contract development market, 2018 - 2030 (USD Million)
  • Fig. 29 Global contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 30 Global preclinical development market, 2018 - 2030 (USD Million)
  • Fig. 31 Global clinical development market, 2018 - 2030 (USD Million)
  • Fig. 32 Veterinary active pharmaceutical ingredients manufacturing market: Therapeutic category & key takeaways (USD Million)
  • Fig. 33 Veterinary active pharmaceutical ingredients manufacturing market: Therapeutic Category movement & market share analysis, 2023 & 2030
  • Fig. 34 Global antiparasitics market, 2018 - 2030 (USD Million)
  • Fig. 35 Global Anti-infectives market, 2018 - 2030 (USD Million)
  • Fig. 36 Global NSAIDs market, 2018 - 2030 (USD Million)
  • Fig. 37 Global Others market, 2018 - 2030 (USD Million)
  • Fig. 38 Regional market place: Key takeaways
  • Fig. 39 Regional outlook, 2023 & 2030
  • Fig. 40 North America veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 44 UK veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 45 Germany veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 46 France veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 54 China veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 55 India veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 61 Mexico veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 63 MEA veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 66 Saudi Arabia veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait veterinary active pharmaceutical ingredients manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 68 Market participant categorization
  • Fig. 69 Heat map analysis